Work

OA07.09 Sintilimab in Combination with Anlotinib as First-Line Therapy for Advanced NSCLC: Final Analysis of Primary Endpoints

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.01.300

Authors: B. Han, T. Chu, R. Zhong, H. Zhong, B. Zhang, W. Zhang, C. Shi, J. Qian, Y. Zhang, Q. Chang, X. Zhang, Y. Dong, J. Teng, Z. Gao, H. Qiang, W. Nie, Y. Zhao, Y. Han, Y. Chen

Institution: Shanghai Chest Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3136906377

Cites:

Cited by: 2

Related to: 10